---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-200429"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2022-07-25T23:59:59+00:00"
generated_at: "2026-06-24T09:17:41.751600+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ginkgo to acquire Bayer's agricultural biologics R&D platform for ~$83M

## Summary
- Ginkgo acquires Bayer's 175,000 sq ft West Sacramento Biologics R&D site and team for ~$83M in cash or stock.
- Three-year strategic partnership with Bayer on nitrogen fixation, crop protection, and carbon sequestration.
- Ginkgo to also integrate Joyn Bio R&D platform assets; deal expected to close Q4 2022.
- Ginkgo may earn royalties on net sales from products developed under the Bayer collaboration.
- Expands Ginkgo's agricultural biologicals platform; cash proceeds from collaboration offset acquired expenses.

## SEC filing metadata
- accession: 0001193125-22-200429
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2022-07-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000119312522200429/0001193125-22-200429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000119312522200429/d368669d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-200429
- JSON: https://secwatch.observer/filing/0001193125-22-200429.json
- Plain text: https://secwatch.observer/filing/0001193125-22-200429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.